Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Remifentanil for Skull Pin Fixation
NCT06331663Phase 4Not yet recruiting
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil in procedural pain, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06331663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06331663.